share_log

基石藥業-B:(1)截至二零二二年六月三十日止六個月中期業績公告;(2)本公司首席執行官、執行董事、戰略委員會主席及授權代表停任;及(3)委任本公司首席執行官、執行董事、戰略委員會主席及授權代表

CSTONE PHARMA-B: (1) ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022; (2) CESSATION TO ACT AS THE CHIEF EXECUTIVE OFFICER, THE EXECUTIVE DIRECTOR, THE CHAIRMAN OF THE STRATEGY COMMITTEE AND AN AUTHORIZED REPRESENTATIVE; AND (3) APPOI

Aug 25, 2022 05:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more